Une veille sur la santé numérique en France et à l’international : politiques publiques, données, infrastructures, IA, services et usages. Études, rapports et retours de terrain sélectionnés par Lionel Reichardt, Pharmageek, pour comprendre les transformations et éclairer les décisions.
 Your new post is loading...
Your new post is loading...
Scoop.it!
Growth in the numbers of Apple and Android devices has extended the potential reach of biopharma apps, and companies have responded by diversifying their output. As well as adherence, diary and text-based education apps, this year's list features a mutant-cheese-fighting game from Genentech, a glaucoma simulation from Merck ($MRK) and a real-time bus schedule from Biogen Idec ($BIIB).
Via Philippe Marchal 
No comment yet.
Sign up to comment
Scoop.it!
A l’inverse des secteurs du luxe et de la grande distribution, l’industrie pharmaceutique en France ne tire pas encore pleinement parti du digital. Via Pharmacomptoir / Corinne Thuderoz
Scoop.it!
RT @OrangeHCare: La #m-santé fait une entrée remarquée au cabinet médical par @idssante http://t.co/5CziuPKeIO #hcsmeufr #esanté Via Pharmacomptoir / Corinne Thuderoz, Coralie Bouillot
Scoop.it!
Pour ceux qui ont pu assister à la soirée que nous avons organisée le mercredi 16 octobre à Cannes, nous tenions à les remercier pour leur présence et, pour ceux qui n’ont malheureusement pas pu venir, nous tenions à partager avec eux une synthèse... Via Emmanuel Capitaine
Scoop.it!
That's the finding of a new report on mobile health apps by IMS Institute for Healthcare Informatics (free PDF here). In true mobile fashion, it's also available in the iTunes store (here). Via dbtmobile
Scoop.it!
There are more than 43,000 healthcare apps available from the US iTunes store, but only about 16,275 of those are patient-facing apps with “genuine” health content, according to a new study from IMS Health.
Scoop.it!
Brief profiles of entrepreneurs changing healthcare with digital applications. How will YOU change healthcare? Via Sam Stern, Giuseppe Fattori, George Huba
Scoop.it!
eMedToday's curator insight,
October 29, 2013 8:09 PM
As one author said: Smartphones are our brain health
eMedToday's curator insight,
October 29, 2013 8:09 PM
Pharmas need to understand that phones are center in health care and HCP professionals
eMedToday's curator insight,
October 29, 2013 8:20 PM
Again with such high usage of smartphones and relatively low number of Pharma apps, the mobile app area should be a high focus for Pharma in both consumer and doctor area
Scoop.it!
Are health networks, social media efforts and analytics ready for prime time to fight the flu? One of the influenza strains that afflicted New Yorkers in 2012 was so sneaky that it even fooled Pascal Imperato, M.D., the former head of the city's health department, a renowned expert on infectious diseases, and now dean of the school of public health at SUNY Downstate Medical Center in Brooklyn. If the subtle early symptoms had been more widely known and publicized, Imperato might have saved himself a week in bed and a month of feeling not quite himself. The prevailing techniques of flu surveillance-tracking test results and reports of "influenza-like illness"-are blunt instruments for providing that kind of information, but they're being supplemented increasingly by information gleaned from sophisticated lab testing, social media, electronic health records and simply asking people to report whether they have the flu. These new information streams, properly analyzed and integrated, can help providers see disease patterns even among people who don't go to the doctor or the hospital, can give early warning when a virus has undergone changes or presents in an unfamiliar way, and can produce a complete picture of the overall human toll and cost of a season of flu. This type of detail will be increasingly important as providers become responsible not just for episodic care of the sick but for keeping people healthy. "Influenza is a disease where the predictable doesn't occur and the unpredictable does," Imperato says. "Even with tracking, things come up that are a total surprise." The Centers for Disease Control, in cooperation with state health departments and a network of labs and providers (both physician offices and hospitals) tracks the essentials: flu test results, the number of people visiting doctors or hospitals with influenza-like illnesses (ILIs), hospitalization and mortality. During flu season, state health departments also issue weekly estimates of how widespread the flu is. Getting a Grip on the Data Today's flu surveillance can go far beyond who does or doesn't have the flu, and will go even further as researchers, providers and public health officials figure out ways to link one dataset to another. Which data stream is most useful? Depends on what you want to know: CMS claims data: Tracks incidence of the flu and the treatment that resulted, using ICD codes. Good for looking at the big picture of the flu season especially among the elderly, but hampered by a time lag of weeks to months between the event and the availability of the data. CDC ILINet: Tracks the number of visits to "sentinel providers" by people with influenza-like illness (defined as cough, fever and sore throat), as a percentage of the total number of visits. Good for confirming that the flu has arrived in your area and tracking how it has affected different age groups. CDC NREVSS (National Respiratory and Enteric Virus Surveillance System):Tracks positive flu tests as a percent of the total, from participating labs. Good for confirming when influenza-like illnesses are actually flu, which flu is where, and whether the vaccine being used in a given year is a good match for the strains that are circulating. Google Flu Trends: Tracks flu-related search terms and various online news sources for flu mentions. Good for tracking awareness of and concern about the flu. HealthMap: Tracks worldwide reports of disease outbreaks in close to real time based on trusted sources like governments and non-government organizations. A sub-project, Flu Near You, asks people to report their experiences directly. Twitter (as distilled by Social Health Media and others): Analyzes tweets mentioning flu or flu-like illness. Good for tracking how sick people are (or at least how much they complain about it), how often flu keeps people out of work (specifically the group sick enough to stay home but not too sick to tweet). The same type of analysis can be applied to Facebook posts and other forms of social media. Health information exchanges: Still in embryo most places as a flu surveillance tool, but likely to increase in importance as HIEs become more widely adopted. Potentially good for tying together the reports of ILI and reports of later complications or hospitalizations among those same patients, and for tracking reports of flu among people who have been vaccinated. Electronic health records: Also still in embryo in most locations, but likely to increase in importance as meaningful use requirements help standardize data elements. Good for tracking flu rate, vaccination rate, rate of flu in vaccinated people, rate of complications and hospitalizations for flu, with cross analysis by demographics and other health conditions, outcomes of treatment, mortality, individual experiences with the flu over time. Via nrip
Scoop.it!
Allocations familiales, médecins, mutuelles : ce qui changera en 2014
Scoop.it!
David Foord's curator insight,
October 28, 2013 11:38 AM
NHS Employers has produced a new infographic showing the organisations that support the new NHS and what they do.
Scoop.it!
When a startup gets ready for some M&A action (and if they’re in healthcare, getting to this point was probably hard-fought and hard-won), a patent troll could come knocking. Via Emmanuel Capitaine
Scoop.it!
As the Affordable Care Act unfolds, start-ups are finding business opportunities in helping the staid health care industry adapt quicker. Via Bart Collet
|
Scoop.it!
Scoop.it!
“The IMS Institute for Healthcare Informatics released a report on the ecosystem bloody mess of 40,000+ mobile health apps that are available today. Hat tip to Jane Sarasohn-Kahn for writing about it today at Health Populi.”
Scoop.it!
A quelques kilomètres de Nice, le centre de solutions métiers d’IBM de La Gaude a développé une expertise mondiale en santé. Via Philippe Loizon
Scoop.it!
Les grands laboratoires mondiaux se sont profondément transformés pour faire face à un environnement hostile. Le retour de la croissance et de l’innovation devrait soutenir les cours. Via Cabinet Bidault - Transaction Pharmaceutique
Scoop.it!
Officiellement, les Serious Games seraient nés en 2002, via « America Army » jeu de simulation des exercices d’entrainement de l’armée américaine.
Scoop.it!
Eye On FDA's Mark Senak is keeping tabs on pharma's social media assets, including activity in Twitter, Facebook, YouTube, Pinterest and Google+.
Scoop.it!
Many pharmaceutical companies are working to find their own space in this growing market. Today, nearly 250 pharmaceutical company mobile applications exist for iOS and Android platforms. However, many of these apps ... Via eMedToday
eMedToday's curator insight,
October 29, 2013 8:14 PM
Many pharmaceutical companies are working to find their own space in this growing market. Today, nearly 250 pharmaceutical company mobile applications exist for iOS and Android platforms. However, many of these apps have low download rates and are quickly deleted by users. Sanofi-Aventis has a successful mobile app portfolio, which boasts more than 1 million downloads; however, this success is low compared to out-of-industry health applications, such as physician-facing Healthtap, which counts multiple millions of users.
eMedToday's curator insight,
October 29, 2013 8:16 PM
An area of real opportunity for Pharma is to develop an e detailing app.
None exist.
Scoop.it!
Few publications that consider the pharmaceutical industry’s participation in digital environments neglect to mention ‘marketing’ in some capacity.
We genuflect to ‘marketing’ so freely, deploy it in our discourse with such profligate frequency, and elevate the study of its operations to such a degree that a casual observer could be led to imagine that the concept of ‘marketing’ was in some way intrinsic to every facet of a pharmaceutical company’s success.
‘No marketing, no pharmaceutical company,’ one might conclude, as if no prescription would ever be written, nor any course of treatment embarked upon without it.
However, the premise upon which this post is based is that the exact opposite is in fact true, and that the continued pursuit of ‘marketing’ by the pharmaceutical industry as it is currently practiced has the potential to irreparably damage the industry’s reputation, further undermine health consumer trust in its operations, impact upon its profitability, and undermine the viability of its future operations.
Scoop.it!
Check out ICF new infographic based on our research at the intersection of healthcare and mobile technology. Well… it’s more than an infographic. It’s also a set of guiding principles for healthcar... Via Plus91
Scoop.it!
Most people agree that doing robust studies and pilots is important to the development of mobile and digital health, and to reaching the cost savings these technologies offer. But what kind of evidence is important?
When is it time to stop running pilots and go to scale, and what challenges does that process offer?
And furthermore, does every provider organization have to reinvent the wheel, or can they learn from each others’ pilots?
Scoop.it!
La baisse de la productivité de la recherche pharmaceutique oblige les laboratoires à réorganiser leurs propres forces et à ouvrir davantage leur rech... Via Sophie Bariteau
Carlos Adanero Oslé's curator insight,
November 4, 2013 1:54 PM
Visión de Francia en el doloroso tema de la escasez de rendimiento de la investigación.
Scoop.it!
CSOJ du 25 octobre 2013 Toutes les informations sur les invités, thèmes et live: http://bit.ly/1g0ZI5C Présentation des invités de CSOJ - 25 octobre 2013 CSO... Via Esposito Christelle, Rémy TESTON, Giuseppe Fattori
|
